FDA approves Teva's generic nasal spray to treat opioid overdose

Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval from the U.S. Food and Drug Administration (FDA) to market its generic nasal spray for opioid overdose, the health regulator said.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news